Alyeska Investment Group, L.P. 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Purchase |
2024-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Alyeska Investment Group, L.P. | 6,707,497 5.760% |
1,725,824 (+34.64%) |
Filing |
| 2024-11-14 4:38 pm Sale |
2024-09-30 | 13G | Applied Therapeutics, Inc. APLT |
Alyeska Investment Group, L.P. | 4,981,673 4.200% |
-2,733,524 (-35.43%) |
Filing |
| 2024-02-14 1:50 pm Purchase |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Alyeska Investment Group, L.P. | 7,715,197 9.990% |
2,910,197 (+60.57%) |
Filing |
| 2023-02-14 2:04 pm Purchase |
2022-12-31 | 13G | Applied Therapeutics, Inc. APLT |
Alyeska Investment Group, L.P. | 4,805,000 9.990% |
4,805,000 (New Position) |
Filing |